Filing Details

Accession Number:
0001181431-13-000830
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-03 14:38:40
Reporting Period:
2012-12-31
Filing Date:
2013-01-03
Accepted Time:
2013-01-03 14:38:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Pharma Inc. HZNP Pharmaceutical Preparations (2834) 272179987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1523672 N Todd Smith C/O Horizon Pharma, Inc.
520 Lake Cook Road, Suite 520
Deerfield IL 60015
Evp & Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-31 22,500 $0.00 29,568 No 4 A Direct
Common Stock Disposition 2013-01-02 6,998 $2.36 22,570 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee stock options (right to buy) Acquisiton 2013-01-02 61,000 $0.00 61,000 $2.40
Common Stock Restricted stock units Acquisiton 2013-01-02 55,000 $0.00 55,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
61,000 2023-01-01 No 4 A Direct
55,000 No 4 A Direct
Footnotes
  1. On January 3, 2012, the reporting person was granted restricted stock units which vest upon the achievement of certain performance criteria. On December 31, 2012, 22,500 of these restricted stock units vested in connection with the achievement of certain of these performance related goals. No unvested restricted stock units with respect to this grant were outstanding after the completion of this transaction.
  2. Includes 3,719 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
  3. Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
  4. The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013.
  5. Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
  6. The restricted stock units vest in four equal annual installments beginning January 2, 2014.